Researchers from Israel are the latest to show that AI and deep learning could make the drug discovery process more efficient, by getting a computer to learn the “vocabulary” of
Machine learning is widely predicted to make drug discovery and patient diagnosis quicker, cheaper and more effective in the future, and signs of this can already be seen.
Artificial Intelligence (AI) technology co-developed by DeepMind and Moorfields Eye Hospital in London shows a potential to work alongside ophthalmologists to accelerate the diagnosis and h
“Adapt or become irrelevant” is the stark message that Janssen’s Company Group Chairman for Europe, Middle East and Africa (EMEA), Kris Sterkens, has for pharma companies that fail to embrace t
